| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |